Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORGO
DateTimeSourceHeadlineSymbolCompany
05/09/202406:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in SeptemberNASDAQ:ORGOOrganogenesis Holdings Inc
16/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202406:44Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202406:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202406:04GlobeNewswire Inc.Organogenesis Shares ReNu® Program UpdateNASDAQ:ORGOOrganogenesis Holdings Inc
19/07/202407:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
16/07/202406:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
07/06/202406:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202406:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202406:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
02/05/202421:00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
16/04/202421:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
03/04/202422:30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
01/03/202408:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
01/03/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
01/03/202408:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
24/02/202409:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202412:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202412:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202412:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ORGO